HTFL NASDAQ
Credit Risk of going bust: lower than 67% of companies Debt: 0.5% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.06 (down 99.9%), Heartflow, Inc. Common Stock would be worth roughly what it owes.
Total debt $27.1M against a stock market value of $4.96B.
Distance to default 7.12 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.0M (short-term plus half of long-term), stock volatility 76.5%; Altman Z'' -4.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
San Francisco, CA 94105
US
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Rogers Campbell | S-Sale | 23,933 | $55.01 | 2026-10-22 |
| Farquhar John C.M. | S-Sale | 38,900 | $49.57 | 2026-10-12 |
| Rogers Campbell | S-Sale | 19,682 | $50.15 | 2026-09-18 |
| Verghese Vikram | S-Sale | 16,766 | $50.75 | 2026-09-18 |
| Verghese Vikram | S-Sale | 7,579 | $50.11 | 2026-09-17 |